CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,089 | +4.1% | 16,767 | +40.3% | 0.00% | -33.3% |
| Q2 2023 | $1,624,291 | +21.9% | 11,952 | -6.8% | 0.00% | 0.0% |
| Q1 2023 | $1,332,130 | +39.9% | 12,823 | +19.3% | 0.00% | +50.0% |
| Q4 2022 | $952,382 | +4.3% | 10,751 | -5.7% | 0.00% | 0.0% |
| Q3 2022 | $913,000 | -0.7% | 11,396 | +18.8% | 0.00% | 0.0% |
| Q2 2022 | $919,000 | -49.8% | 9,593 | -6.5% | 0.00% | -50.0% |
| Q1 2022 | $1,829,000 | +30.6% | 10,257 | +3.9% | 0.00% | +33.3% |
| Q4 2021 | $1,400,000 | +31.6% | 9,874 | +21.5% | 0.00% | +50.0% |
| Q3 2021 | $1,064,000 | +8.1% | 8,130 | +13.6% | 0.00% | 0.0% |
| Q2 2021 | $984,000 | +8.4% | 7,157 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $908,000 | +42.1% | 6,948 | +21.7% | 0.00% | 0.0% |
| Q4 2020 | $639,000 | -17.5% | 5,707 | -41.9% | 0.00% | 0.0% |
| Q3 2020 | $775,000 | +37.9% | 9,829 | +26.3% | 0.00% | 0.0% |
| Q2 2020 | $562,000 | +23.8% | 7,784 | -1.8% | 0.00% | 0.0% |
| Q1 2020 | $454,000 | – | 7,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |